Exodus Point Capital Management, LP Avrobio, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$0.75 - $1.33 $7,889 - $13,990	-10,519 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $3,559 - $11,146	-2,759 Reduced 20.78%	10,519 $14,000
Q4 2021 Feb 11, 2022	SELL	$3.45 - $6.05 $40,037 - $70,210	-11,605 Reduced 46.64%	13,278 $51,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $25,238 - $42,353	4,564 Added 22.46%	24,883 $139,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $159,300 - $256,019	20,319 New	20,319 $181,000

28.1M

100

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.